6DN7
SPRY domain-containing SOCS box protein 2 complexed with WDINNN(BAL) Cyclic peptide inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2016-03-23 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.95370 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 54.690, 65.440, 69.180 |
Unit cell angles | 90.00, 103.60, 90.00 |
Refinement procedure
Resolution | 32.610 - 1.400 |
R-factor | 0.198 |
Rwork | 0.197 |
R-free | 0.21300 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.020 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | BUSTER (2.10.3) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 32.610 | 1.480 |
High resolution limit [Å] | 1.400 | 1.400 |
Rmerge | 0.048 | 0.474 |
Rpim | 0.031 | 0.324 |
Number of reflections | 91682 | |
<I/σ(I)> | 12.7 | 2.4 |
Completeness [%] | 98.3 | |
Redundancy | 4.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 5.9 | 277.15 | 0.2 M Magnesium chloride hexahydrate 20 % w/v PEG 3350 |